https://www.targetedonc.com/view/exploration-of-plk1-inhibition-in-advanced-cancers-begins
0
0
9/21/23 at 6:00pm
Organization
Targetedonc.com
Author
Nichole Tucker
The investigational PLK1 inhibitor, CYC140, is the focus of important clinical research in advanced solid tumors, leukemias, and lymphomas.
Create an account
or login to join the discussion